Saturday, October 5, 2024

Cancer Care Revolutionized: Moffitt and Reimagine Care Partner to Expand On-Demand Treatment

Similar articles

Subscribe Weekly Market Access News

* indicates required

Key Takeaways

  • The partnership between Reimagine Care and Moffitt Cancer Center enhances access to virtual and home-based cancer care, providing patients with personalized, on-demand support.
  • This collaboration marks a significant step in advancing the CancerX initiative, aligning with the goals of the Cancer Moonshot to improve cancer care accessibility and patient outcomes.
  • By leveraging innovative care models, the partnership aims to revolutionize cancer treatment, allowing patients to receive seamless care both in clinical settings and at home.

Reimagine Care, a leading provider of on-demand cancer care services in the U.S., has announced a strategic partnership with Moffitt Cancer Center, Florida’s only National Cancer Institute-designated Comprehensive Cancer Center, and a key player in the CancerX initiative. This collaboration is set to revolutionize cancer care by increasing flexibility and allowing patients to receive treatment outside traditional healthcare environments.

Under this partnership, Reimagine Care will offer round-the-clock, proactive, virtual, and home-based cancer care services to Moffitt patients. This innovative care delivery model aims to improve patient outcomes by providing personalized, on-demand care wherever and whenever it’s needed. By utilizing Reimagine Care’s platform, the partnership ensures Moffitt patients can access care that aligns with both organizations’ commitment to making cancer treatment more accessible and patient-focused.

Reimagine Care and Moffitt Cancer Center Unite to Advance Revolutionary Cancer Care through CancerX Initiative

“Partnering with Moffitt, a recognized leader in cancer research and treatment, is a tremendous honor for Reimagine Care,” said Dan Nardi, CEO of Reimagine Care. “This collaboration brings revolutionary, on-demand care directly to patients, giving them the support and resources they need throughout their cancer journey. It also marks one of the first significant partnerships to arise from the CancerX initiative, helping to advance the goals of the Cancer Moonshot.”

Moffitt Cancer Center, renowned for its pioneering efforts in cancer research, and patient care, and hosting the CancerX initiative, plays a crucial role in accelerating innovative cancer treatments and care models. Reimagine Care, as a founding member of CancerX, shares this mission and is dedicated to helping achieve the initiative’s ambitious targets.

Cancer Care

Moffitt and Reimagine Care Partnership Enhances Patient Experience with Seamless, On-Demand Cancer Treatment

“This partnership with Reimagine Care ensures that our patients receive seamless, comprehensive care, whether they are in the clinic or at home,” said Dr. Tim Hembree, Chief Quality Officer at Moffitt. “Through this collaboration, we are improving both outcomes and the overall patient experience by delivering the right care at the right time.”

This collaboration represents a major milestone for CancerX, marking one of the first partnerships developed from the initiative’s accelerator program. By combining innovation with accessible care, Moffitt and Reimagine Care aim to drive progress in cancer treatment and improve the overall experience for cancer patients.

 

You can follow our news on our Telegram, LinkedIn and Youtube accounts.

Resource: Reimagine Care, September 30, 2024


This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article